Video Shift from disease based nomenclature discussed at APNA

In this video, Lyons Hardy, MS, RN, P-MHNP, clinical assistant professor and concentration lead of the psychiatric mental health nurse practitioner program at Virginia Commonwealth University School of Nursing, discussed a presentation she gave with a colleague at the American Psychiatric Nurses Association Annual Conference.

The presentation concerned recommended updates to neuroscience-based nomenclature to identify psychotropic medications, moving away from disease-based nomenclature to prevent confusion among patients.

“The idea is, it’s clearer to identify the drugs by (their chemical name), versus calling them an anxiolytic or an antipsychotic, which are used for many different things,” Hardy said. “It might not be fully clear to use that terminology.”

Reference:

• Hardy et. al. Why Are You Prescribing Me an Antipsychotic for My Depression? Neuroscience-Based Nomenclature for Psychotropic Medications. Presented at: American Psychiatric Nurses Association Annual Conference 2022; October 20-23, 2022; Long Beach, CA.